Medicine
Antimicrobial Stewardship for Multidrug-Resistant Organisms
Quick fact
The CDC estimates that more than 2.8 million antibiotic-resistant infections occur each year in the United States, leading to over 35,000 deaths. Many of these are caused by MDROs that are difficult or impossible to treat.
Why this is interesting
Every time we use an antibiotic, we are racing against evolution. What if the tools we rely on to save lives are being blunted by our own everyday choices?
Read the full explanation
Understanding Antimicrobial Stewardship for Multidrug-Resistant Organisms
Imagine you are a farmer with a limited supply of water, and every day you water your crops—but some days you water them whether they need it or not. The water is precious, and overusing it doesn't make the crops grow better; it just wastes the resource and might even damage the soil. Similarly, antimicrobial stewardship is about using antibiotics exactly when they are needed, at the right dose, for the right duration, and only when the benefits outweigh the risks. The problem is that antibiotics are overprescribed for viral infections or used for longer than necessary, which creates a breeding ground for resistant bacteria. Stewardship programs involve a team of doctors, pharmacists, and infection control specialists who review antibiotic prescriptions, educates prescribers, and implements guidelines to ensure that antibiotics are used wisely. The goal is to slow down the emergence of MDROs and preserve the effectiveness of existing drugs.
A deeper explanation
Antimicrobial stewardship works by reducing 'selection pressure'—the evolutionary force that favors resistant bacteria. When we expose a bacterial population to an antibiotic, susceptible bacteria are killed, while resistant ones survive and multiply. Over time, the resistant strain becomes dominant. By using antibiotics more selectively, we minimize this pressure. Stewardship also optimizes dosing to maximize bacterial killing while minimizing resistance development. Rapid diagnostic tests help identify the exact pathogen quickly, allowing clinicians to switch from broad-spectrum (strong but less targeted) antibiotics to narrow-spectrum ones, a process called 'de-escalation.' Monitoring antibiotic use and resistance patterns helps identify problems early. Stewardship is crucial because new antibiotics are scarce—it can take over a decade and billions of dollars to develop one. Without stewardship, we risk returning to a pre-antibiotic era where routine infections are lethal.